148
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

F-18 Fluorodeoxyglucose PET/CT as a Diagnostic Tool in Orbital Inflammatory Disorders

, MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, , MD, PhD & , MD, PhDORCID Icon show all
Pages 1803-1809 | Received 17 Dec 2020, Accepted 14 Jul 2021, Published online: 28 Jul 2021

References

  • Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease. Semin Arthritis Rheum. 2008;37(4):207–222. doi:10.1016/j.semarthrit.2007.06.003.
  • Abad S, Héran F, Terrada C, et al. Management of orbital inflammation in internal medicine. Proposal for a diagnostic workup. Rev Med Interne. 2018;39(9):746–754. doi:10.1016/j.revmed.2017.12.010.
  • Mombaerts I, Rose GE, Garrity JA. Orbital inflammation: biopsy first. Surv Ophthalmol. 2016;61(5):664–669. doi:10.1016/j.survophthal.2016.03.002.
  • Swamy BN, McCluskey P, Nemet A, et al. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. 2007;91(12):1667–1670. doi:10.1136/bjo.2007.124156.
  • Mombaerts I, Bilyk JR, Rose GE, et al. Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach. JAMA Ophthalmol. 2017;135(7):769–776. doi:10.1001/jamaophthalmol.2017.1581.
  • Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the international Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048–3058. doi:10.1200/JCO.2013.53.5229.
  • Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med. 2006;47(10):1571–1576.
  • Soussan M, Abisror N, Abad S, et al. FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev. 2014;13(2):125–131. doi:10.1016/j.autrev.2013.09.009.
  • Ebbo M, Grados A, Guedj E, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken). 2014;66(1):86–96. doi:10.1002/acr.22058.
  • London J, Soussan M, Gille T, et al. Adult-onset asthma associated with periocular xanthogranuloma: new findings in a very rare systemic disease. Ophthalmic Plast Reconstr Surg. 2013;29(2):104–108. doi:10.1097/IOP.0b013e31827ae96a.
  • Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–1192. doi:10.1038/modpathol.2012.72.
  • Smith TJ, Hegedüs L. Graves’ disease. N Engl J Med. 2016;375(16):1552–1565. doi:10.1056/NEJMra1510030.
  • Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996;335(2):99–107. doi:10.1056/NEJM199607113350206.
  • Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33(8):1101–1107. doi:10.1002/art.1780330807.
  • Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:10.1002/art.37715.
  • Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30. doi:10.1007/s10165-011-0571-z.
  • Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7–19. doi:10.1002/art.41120.18.
  • Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061–3067. doi:10.1002/art.34593.
  • Pencina MJ, D’Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med. 2010;48(12):1703–1711. doi:10.1515/CCLM.2010.340.
  • Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172. doi:10.1002/sim.2929.
  • Decaudin D, De Cremoux P, Vincent-Salomon A, Dendale R, Rouic -L-L-L. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood. 2006;108(5):1451–1460. doi:10.1182/blood-2006-02-005017.
  • McKelvie PA, McNab A, Francis IC, Fox R, O’Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol. 2001;29(6):387–393. doi:10.1046/j.1442-9071.2001.d01-18.x.
  • Valenzuela AA, Allen C, Grimes D, Wong D, Sullivan TJ. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology. 2006;113(12):2331–2337. doi:10.1016/j.ophtha.2006.05.059.
  • Fujii H, Tanaka H, Nomoto Y, et al. Usefulness of 18FDG-PET/CT for evaluating response of ocular adnexal lymphoma to treatment. Medicine (Baltimore). 2018;97(17):e0543. doi:10.1097/MD.0000000000010543.
  • Hui KH, Pfeiffer ML, Esmaeli B. Value of Positron Emission Tomography/Computed Tomography in Diagnosis and Staging of Primary Ocular and Orbital Tumors. Saudi J Ophthalmol. 2012;26(4):365–371. doi:10.1016/j.sjopt.2012.08.008.
  • Klingenstein A, Garip-Kuebler A, Mueller-Lisse UG, Hintschich C. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma. Acta Ophthalmol. 2018;96(6):e712–e717. doi:10.1111/aos.13766.
  • Fang H, Chiu A, Reichard KK. Crystal-storing histiocytosis in bone marrow: a Clinicopathologic Study of Eight Cases and Review of the Literature. Am J Clin Pathol. 2018;149(2):148–163. doi:10.1093/ajcp/aqx150.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.